Quality improvement initiatives to advance and standardize quality of care in patients living with liver disease
Dr. Mayur Brahmania is an Assistant Professor of Medicine at Western University practicing in Hepatology and Transplant Hepatology. He completed his undergraduate and medical degree at the University of Saskatchewan before starting medical residency at the University of British Columbia in Internal Medicine and completing a Gastroenterology fellowship (2011-2013) at the University of Manitoba. He then moved to Toronto for training in general and transplant Hepatology at the Toronto General Hospital: Toronto Centre for Liver Disease along with undertaking a research fellowship and earning a Masters of Public Health (MPH) degree at the Harvard TH Chan School of Public Health in Boston, MA. He also holds advanced certification from the Centre for Quality Improvement and Patient Safety (CQUIPS). Dr. Brahmania is the current chair of the Gastroenterology Quality Improvement and Innovation committee at the University of Western and currently focuses his research interests around quality improvement initiatives to advance and standardize quality of care in patients living with liver disease.
Brahmania M, Renner EL, Coffin CS, Yoshida EM, Wong P, Zeman M, Shah H. Choosing Wisely Canada-Top Five List in Hepatology: Official Position Statement of the Canadian Association for the Study of the Liver (CASL) and Choosing Wisely Canada (CWC). Ann Hepatol. 2019 Jan - Feb;18(1):165-171.
Rush B, Deol N, Teriyaki A, Sey M, Jairath V, Walley KR, Celi LA, Brahmania M. Lower 90-day Hospital Readmission Rates for Esophageal Variceal Bleeding After TIPS: A Nationwide Linked Analysis. J Clin Gastroenterol. 2019 Feb 27.
Ufere NN, Brahmania M, Sey M, Teriaky A, El-Jawahri A, Walley KR, Celi LA, Chung RT, Rush B. Outcomes of in-hospital cardiopulmonary resuscitation for patients with end-stage liver disease. Liver Int. 2019 Feb 27.
Rush B, Fruhstofer C, Walley KR, Celi LA, Brahmania M. Palliative medicine and hospital readmissions in end-stage liver disease. BMJ Support Palliat Care. 2019 Feb 13.
Rush B, Walley KR, Celi LA, Rajoriya N, Brahmania M. Palliative care access for hospitalized patients with end-stage liver disease across the United States. Hepatology. 2017 Nov; 66(5):1585-1591.
Moore, M., Fricker, J., Leigh, R., Brahmania, M., van Hazel, G. Palliative Care in ESLD Patients. British Journal of Hospital Medicine. 2017 78 (8):428-431.
Rush, B., Walley, K., Celi, A., Rajoriya, N., Brahmania, M. Palliative Care Access for Hospitalized Patients with End Stage Liver Disease Across the United States. Hepatology. 2017 Jun 29.
Brahmania, M., Ahmed, O., Sherman, M., et al. Delayed Radio Frequency Ablation Treatment of Hepatocellular Carcinoma is Associated with Adverse Clinical Outcomes. Ann Hepatol. 2017 Aug 8;16 (5): 765-771.
Brahmania, M., Brouwer, W.P., Wong, D.K., Feld, J.J., Janssen, H.L.A. Prevalence and Risk Factors for Viral Blipping During Nucleos(t)ide Analogue Treatment in Chronic HBV Infection. J Viral Hepat. 2016 Dec; 23(12): 1003-1008.
Weizman, AV., Mosko, J., Bollegala, N., Bernstein, M,, Brahmania, M., et al. Launching a Quality Improvement Initiative. Clin Gastroenterol Hepatol. 2016 Aug;14(8):1067-71.
Bollegala, N., Patel, K., Mosko, J., Bernstein, M., Brahmania, M., et al. How to Measure and Display Quality Improvement Data. Clin Gastroenterol Hepatol. 2016 Sep;14(9):1230-3.
Bernstein, M., Hou, JK., Weizman, AV., Mosko, J., Bollegala, N., Brahmania, M., et al. How to Sustain a Quality Improvement Effort. Clin Gastroenterol Hepatol. 2016 Oct;14(10):1371-5.
Brahmania, M., Feld, J., Arif, A., Janssen, HLA. Chronic Hepatitis B Treatment: A Roadmap to Cure From Now to the Future. Lancet Infect Dis. 2016 Feb;16 (2):e10-21.
Brahmania M., Enns, R., et al. 2L vs. 4L PEG 3350 + Electrolytes for Outpatient Colonic Preparation: A Randomized Controlled Trial. Gastrointest Endosc 2014 March; 79 (3): 408-16.